Clinical and histological staging as prognostic determinants in advanced cutaneous T cell lymphomas treated by sequential polychemotherapy with bleomycin, vinblastine and prednisone. Preliminary results.
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols; D001761:Bleomycin / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009182:Mycosis Fungoides / Q000188:drug therapy; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use; D011379:Prognosis; D012878:Skin Neoplasms / Q000188:drug therapy*; D013601:T-Lymphocytes; D014747:Vinblastine / Q000008:administration & dosage / Q000627:therapeutic use
D001761:Bleomycin; D014747:Vinblastine; D011241:Prednisone